HU9400932D0 - Linear adhesion inhibitors - Google Patents

Linear adhesion inhibitors

Info

Publication number
HU9400932D0
HU9400932D0 HU9400932A HU9400932A HU9400932D0 HU 9400932 D0 HU9400932 D0 HU 9400932D0 HU 9400932 A HU9400932 A HU 9400932A HU 9400932 A HU9400932 A HU 9400932A HU 9400932 D0 HU9400932 D0 HU 9400932D0
Authority
HU
Hungary
Prior art keywords
adhesion inhibitors
linear adhesion
linear
inhibitors
adhesion
Prior art date
Application number
HU9400932A
Other languages
English (en)
Inventor
Beate Diefenbach
Brunhilde Felding-Habermann
Alfred Jonczyk
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of HU9400932D0 publication Critical patent/HU9400932D0/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546—Integrin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
HU9400932A 1993-04-01 1994-03-31 Linear adhesion inhibitors HU9400932D0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4310632A DE4310632A1 (de) 1993-04-01 1993-04-01 Lineare Adhäsionsinhibitoren

Publications (1)

Publication Number Publication Date
HU9400932D0 true HU9400932D0 (en) 1994-06-28

Family

ID=6484423

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9400932A HU9400932D0 (en) 1993-04-01 1994-03-31 Linear adhesion inhibitors

Country Status (10)

Country Link
EP (1) EP0618225A1 (hu)
JP (1) JPH06321988A (hu)
CN (1) CN1099040A (hu)
AU (1) AU5798494A (hu)
CA (1) CA2120302A1 (hu)
CZ (1) CZ70394A3 (hu)
DE (1) DE4310632A1 (hu)
HU (1) HU9400932D0 (hu)
NO (1) NO941151L (hu)
SK (1) SK38494A3 (hu)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770565A (en) * 1994-04-13 1998-06-23 La Jolla Cancer Research Center Peptides for reducing or inhibiting bone resorption
US5874562A (en) * 1995-06-07 1999-02-23 Progenitor, Inc. Nucleic acid encoding developmentally-regulated endothelial cell locus-1
CA2230209A1 (en) 1995-08-30 1997-03-06 G.D. Searle & Co. Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists
US6100423A (en) * 1995-08-30 2000-08-08 G. D. Searle & Co. Amino benzenepropanoic acid compounds and derivatives thereof
IL125756A (en) 1996-02-15 2003-05-29 Biosense Inc Catheter for use in surgery
US6443974B1 (en) 1996-07-28 2002-09-03 Biosense, Inc. Electromagnetic cardiac biostimulation
ES2255155T3 (es) 1998-02-05 2006-06-16 Biosense Webster, Inc. Dispositivo para la administracion intracardiaca de farmacos.
KR20010109275A (ko) 1998-12-23 2001-12-08 로저 에이. 윌리암스 종양치료의 병용치료로서 사이클로옥시게나제-2 억제제와기질 금속단백분해효소 억제제를 사용하는 방법
US6858581B2 (en) 2000-06-16 2005-02-22 Arizona State University Chemically-modified peptides, compositions, and methods of production and use
GB0323378D0 (en) * 2003-10-07 2003-11-05 Univ Leicester Therapeutic agent
USRE46830E1 (en) 2004-10-19 2018-05-08 Polypeptide Laboratories Holding (Ppl) Ab Method for solid phase peptide synthesis
KR20100059859A (ko) * 2007-09-11 2010-06-04 몬도바이오테크 래보래토리즈 아게 치료제로서의 ｃ형 나트륨이뇨 펩티드 단독 또는 뉴로펩티드 ａｆ와의 배합물의 용도
US20100204157A1 (en) * 2007-09-11 2010-08-12 Dorian Bevec Use of a peptide as a therapeutic agent
CN106279362B (zh) * 2015-06-23 2019-07-12 首都医科大学 Arg-Leu-Val-Cys-Val，其合成，药理活性和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5049659A (en) * 1988-02-09 1991-09-17 Dana Farber Cancer Institute Proteins which induce immunological effector cell activation and chemattraction
US5196511A (en) * 1989-12-01 1993-03-23 The Scripps Research Institute Peptides and antibodies that inhibit integrin-ligand binding

Also Published As

Publication number Publication date
DE4310632A1 (de) 1994-10-06
SK38494A3 (en) 1995-02-08
CN1099040A (zh) 1995-02-22
NO941151D0 (no) 1994-03-29
AU5798494A (en) 1994-10-06
CA2120302A1 (en) 1994-10-02
CZ70394A3 (en) 1994-12-15
EP0618225A1 (de) 1994-10-05
JPH06321988A (ja) 1994-11-22
NO941151L (no) 1994-10-03

Similar Documents

Publication Publication Date Title
PL320995A1 (en) Fibronectin adhesion inhibitors
AU2067892A (en) Corrosion inhibitors
HU9601508D0 (en) Dp-iv-serine protease inhibitors
PL304270A1 (en) Pipeline
EP0835109A4 (en) PYRIDINONE-BASED THROMBIN INHIBITORS
GR3033293T3 (en) Cyclic adhesion inhibitors
PL321759A1 (en) Novel thrombosin inhibitors
AU648907B2 (en) Corrosion inhibitors
IL123653A0 (en) Chemokine inhibitor
HUP9903631A3 (en) Adhesion inhibitors
HU9400932D0 (en) Linear adhesion inhibitors
GB9315846D0 (en) Tumour inhibitors
GB9425925D0 (en) Labelling
HU9503783D0 (en) Squvalen syntetase inhibitors
DE69523450D1 (en) Inhibitor
GB9321917D0 (en) Corrosion inhibitors
ZA949525B (en) Enzyme inhibitors
GB9319252D0 (en) Pathway inhibitors
PL314796A1 (en) Wet-wiping floor-care coating
GB9308946D0 (en) Macrophage adhesion
GB9315163D0 (en) Macrophage adhesion
GB9322571D0 (en) Adhesives
GB9319663D0 (en) Enzyme inhibitors
GB9324981D0 (en) Enzyme inhibitors
ZA934819B (en) Cyclic adhesion inhibitors.